Vimta Labs Limited
NSE: VIMTALABS · Healthcare Research, Analytics & Technology · sector
₹489.25NSE close 2026-10-26
Key numbers
Market cap₹2,185 cr
Price₹489.25
52w high / low₹735 / ₹376
P/E27.4xSector median 27.9x
P/B4.8xSector median 3.0x
Book value₹102.3
Dividend yield0.20%Sector median 0.34%
ROE19.1%Sector median 6.1%
ROCE23.5%Sector median 9.8%
OPM34.3%Sector median 8.4%
Debt / equity0.01xSector median 0.01x
EV/EBITDA14.8xSector median 14.8x
Interest cover99.3x
Current ratio3.43x
Sales growth 3y+8.9%Sector median +7.2%
Profit growth 3y+17.9%Sector median -13.6%
PEG1.55x
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 9 companies in Healthcare Research, Analytics & Technology (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹67 cr vs borrowings ₹3 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 99.3x in the last 12 months.
- No promoter shares are pledged.
- Operating cash flow was below net profit in 0 of the last 5 years.
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 14% of net profit in the last 12 months.
- Dividend paid in 5 of the last 5 financial years.
- Price ₹489.25 on 2026-10-26: -33.4% from the 52-week high, +30.1% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹1,118.75 · low ₹398.95
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 83 | 89 | 94 | 98 | 102 | 99 | 109 | 109 |
| EBITDA | 29 | 32 | 33 | 34 | 34 | 33 | 39 | 37 |
| OPM % | 34.8% | 36.5% | 35.0% | 34.5% | 33.6% | 33.1% | 36.0% | 34.2% |
| Other income | 1 | 1 | 2 | 2 | 3 | 2 | 3 | 4 |
| Net profit | 15 | 21 | 18 | 19 | 20 | 18 | 21 | 21 |
| EPS (₹) | 3.29 | 4.72 | 4.11 | 4.25 | 4.46 | 3.96 | 4.73 | 4.71 |
| Revenue YoY | +22.5% | +11.4% | +15.7% | +11.8% | ||||
| Profit YoY | +36.5% | -16.3% | +15.2% | +11.4% |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 276 | 315 | 313 | 344 | 407 | 419 |
| EBITDA | 79 | 94 | 84 | 122 | 140 | 144 |
| Net profit | 41 | 47 | 39 | 67 | 78 | 80 |
| EPS (₹) | 9.29 | 10.69 | 8.76 | 15.14 | 17.40 | 17.86 |
| Revenue growth | +14.2% | -0.7% | +9.9% | +18.4% | +15.2% | |
| Profit growth | +15.2% | -17.9% | +73.5% | +15.1% | +9.4% | |
| Dividend / share (₹) | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +8.9% | +14.3% | +15.2% |
| Net profit | +17.9% | +29.5% | +9.4% |
| EPS | +17.6% | +29.3% | – |
| Share price | – | +31.8% (2y) | -28.8% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 281 | 316 | 379 | 457 |
| Borrowings | – | 15 | 19 | 9 | 3 |
| Cash & equivalents | – | 39 | 24 | 33 | 67 |
| Total assets | – | 360 | 396 | 467 | 562 |
| Fixed assets | – | 156 | 154 | 224 | 300 |
| Capital work in progress | – | 12 | 59 | 38 | 18 |
| Investments | – | 6 | 6 | 0 | 0 |
| Receivables | – | 80 | 86 | 106 | 106 |
| Inventory | – | 23 | 25 | 25 | 30 |
| Payables | – | 14 | 8 | 10 | 12 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 59 | 87 | 59 | 95 | 147 |
| Cash from investing | -38 | -57 | -75 | -76 | -130 |
| Cash from financing | -16 | -11 | -2 | -17 | -10 |
| Capex | 39 | 50 | 75 | 79 | 100 |
| Free cash flow | 20 | 37 | -16 | 15 | 47 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 16.9% | 12.3% | 17.8% | 17.0% |
| ROCE % | – | 22.5% | 16.0% | 23.5% | 22.8% |
| Debtor days | – | 93 | 101 | 113 | 95 |
| Inventory days | – | 112 | 119 | 128 | 135 |
| Payable days | – | 71 | 40 | 54 | 53 |
| Cash conversion cycle (days) | – | 134 | 180 | 187 | 177 |
| Working capital days | – | 123 | 119 | 131 | 143 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 35.64% |
| FIIs | 5.07% |
| DIIs | 0.48% |
| of which Mutual funds | 0.23% |
| Public (non-institutions) | 58.80% |
| Quarter | Mar 2025 | Jun 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 36.70% | 36.67% | 36.67% | 35.99% | 35.90% | 35.85% | 35.67% | 35.64% |
| Promoter group | % |
|---|---|
| Sivalinga Prasad Vasireddi | 11.63% |
| Vangal Harriman | 6.90% |
| Praveena Vasireddi | 4.70% |
| Telangana State Industrial Development Corporation Limited | 2.64% |
| Rajya Lakshmi Vasireddi | 2.56% |
| Vasireddi Veerabhadra Prasad | 2.30% |
| Sujani Vasireddi | 1.86% |
| Vungal Rajeswari | 0.89% |
| Harita Vasireddi | 0.75% |
| Sireesh Chandra Vungal | 0.73% |
| Sudheshna Vungal | 0.67% |
| Swarna Latha Vasireddi | 0.00% |
| Public holders above 1% | % |
|---|---|
| Eurofins Analytical Services India PVT Ltd | 19.70% |
| LCGC Chromatography Solutions Private Limited | 9.32% |
| Barca Global Master Fund LP | 2.27% |
50,484 shareholders. Pledged: 0.00% of promoter shares.
Peers in Healthcare Research, Analytics & Technology
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| SYNGENE | ₹14,527 cr | 65.4x | 3.0x | 4.6% | 7.0% | 19.8% | +5.4% | 0.35% |
| INDGN | ₹14,472 cr | 36.0x | 4.6x | 13.9% | 17.4% | 16.2% | – | 0.33% |
| SUVEN | ₹6,917 cr | – | 11.7x | -100.5% | -59.5% | -4,155.5% | -19.3% | – |
| VIMTALABS | ₹2,185 cr | 27.4x | 4.8x | 19.1% | 23.5% | 34.3% | +8.9% | 0.20% |
| BI | ₹189 cr | 4.3x | 1.0x | 2.3% | 7.0% | 8.4% | +274.4% | – |
| TAKE | ₹154 cr | 12.1x | 5.0x | 49.8% | 20.1% | -2.0% | -34.1% | – |
| NOVELIX | ₹141 cr | 31.7x | 3.0x | 11.3% | 8.8% | 3.1% | +411.3% | – |
| JSTL | ₹102 cr | 28.5x | 1.4x | 6.1% | 9.8% | 20.5% | +19.4% | 0.97% |
| ADESHWAR | ₹23 cr | 18.0x | 0.9x | 5.5% | 10.2% | 4.9% | -12.0% | – |
All 9 companies in Healthcare Research, Analytics & Technology →
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-06-18 | Dividend | Dividend - Rs 2 Per Share |
| 2025-06-13 | Bonus | Bonus 1:1 |
| 2025-05-30 | Dividend | Dividend - Rs 2 Per Share |
| 2024-07-11 | Dividend | Annual General Meeting/Dividend - Rs 2 Per Share |
| 2023-06-21 | Dividend | Annual General Meeting/Dividend - Rs 2 Per Share |
| 2022-06-16 | Dividend | Annual General Meeting/Dividend - Rs 2 Per Share |
| 2021-06-25 | Dividend | Annual General Meeting/Dividend - Rs 2 Per Share |
| 2020-09-01 | Other | Annual General Meeting |
| 2019-07-18 | Dividend | Annual General Meeting/Dividend - Rs 2 Per Share |
| 2018-08-14 | Dividend | Annual General Meeting/Dividend- Rs 2 Per Share |
| 2017-09-19 | Other | Annual General Meeting |
| 2016-08-25 | Dividend | Annual General Meeting/Dividend Re 1/- Per Share |
| 2015-08-06 | Dividend | Annual General Meeting/Dividend - Re 1/- Per Share |
| 2014-06-27 | Dividend | Annual General Meeting/Dividend Rs 2/- Per Share |
| 2013-05-23 | Dividend | Annual General Meeting / Final Dividend Re.0.60/- Per Equity Share |
| 2012-09-06 | Other | Annual General Meeting |
| 2011-09-15 | Dividend | Annual General Meeting And Dividend Re.0.40 Per Share |
| 2010-09-23 | Dividend | Annual General Meeting And Dividend Re.0.80 Per Share |
| 2009-09-10 | Other | Ann Clsng/Dv-Re.0.80 P Sh |
| 2008-08-28 | Dividend | Agm/Dividend - 40% |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Professional, Scientific and Technical: Other Professional, Scientific and Technical Activities
| Sector | Healthcare |
| Industry | Healthcare Research, Analytics & Technology |
| Sub-industry | Healthcare Research, Analytics & Technology |
| Symbol | VIMTALABS |
| BSE code | 524394 |
| ISIN | INE579C01029 |
| Face value | ₹2.0 |
| Incorporated | 1990-11-16 |
| Website | www.vimta.com |
| Plants (India / abroad) | 9 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.